Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 47Leukemia 28Prostatic Neoplasms 21Burkitt Lymphoma 17Leukemia, Biphenotypic, Acute 15Lymphoma 13Leukemia, Myeloid, Acute 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Large B-Cell, Diffuse 6Recurrence 5Lymphoma, Non-Hodgkin 5Myelodysplastic Syndromes 4Hodgkin Disease 4Pituitary Neoplasms 3Pancreatic Neoplasms 3Neoplasms 3Lymphoma, T-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large-Cell, Anaplastic 3Lymphoma, B-Cell 3Dendritic Cell Sarcoma, Interdigitating 3Breast Neoplasms 3Anemia, Refractory, with Excess of Blasts 3Rhabdoid Tumor 2Polycystic Ovary Syndrome 2Obesity 2Multiple Myeloma 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Leukemia, Myelomonocytic, Juvenile 2

Interventions

Cyclophosphamide 32fludarabine phosphate 30Mycophenolic Acid 24Busulfan 21Antilymphocyte Serum 20Tacrolimus 19Peripheral Blood Stem Cell Transplantation 18Methotrexate 18Melphalan 17Filgrastim 17Whole-Body Irradiation 15Cyclosporine 15thymoglobulin 11fludarabine 11Methylprednisolone 11Cytarabine 11Radiotherapy 10Thiotepa 8Granulocyte Colony-Stimulating Factor 8Cord Blood Stem Cell Transplantation 8Stem Cell Transplantation 7Etoposide 6Clofarabine 6Rituximab 5Azacitidine 5Transplantation 4Sirolimus 4Isotretinoin 4Flow Cytometry 4Antibodies 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Myelomonocytic, Juvenile × Hydrocortisone × Clear all
NCT06247787 2026-04-20

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

Children's Oncology Group

Phase 1 Recruiting
36 enrolled
Other hematologic neoplasm

Leukemia, Myelomonocytic, Juvenile

NCT00003593 2013-06-27

Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome

Children's Oncology Group

Phase 3 Completed
254 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡